UnitedHealthcare TRT Coverage
in Washington — 2026 Guide
UHC covers testosterone therapy through its Medical Benefit Drug Policy. Learn the 2026 PA criteria, formulary tiers, and what the Tier 1 medication copay is, typically $0–20/month.
UnitedHealthcare (UHC) is the largest health insurer in the United States, covering tens of millions of Americans including a large share of Washington state residents through employer plans, individual policies, Medicare Advantage (AARP), and Medicaid managed care. For men with low testosterone, UHC offers solid coverage — with generic injectable testosterone at Tier 1, a 12-month PA approval, and a well-defined set of documentation criteria that Revive's clinical process is built to satisfy.
This guide covers UHC's 2026 TRT coverage rules in full — including the updated Medical Benefit Drug Policy that took effect January 1, 2026, the specific lab criteria required, and what UHC members realistically pay at the pharmacy.
Important distinction: This article discusses how UnitedHealthcare covers testosterone medication at your pharmacy — which is the primary insurance benefit for Revive patients. Revive Low T Clinic is a cash-pay practice. Office visits are paid directly to Revive.
For labs, use your insurance (the lab bills your insurer, not Revive) or pay our discounted price (about $40). Patients may submit itemized receipts toward their out-of-network deductible, but reimbursement is not guaranteed. See how billing works at Revive →
UHC's 2026 Medical Benefit Drug Policy for Testosterone
UnitedHealthcare updated its Medical Benefit Drug Policy for Testosterone Replacement and Supplemental Therapy, effective January 1, 2026. This policy governs PA requirements for testosterone across most UHC commercial and Medicare Advantage plans. It specifies exactly what lab values and clinical documentation are needed for approval and provides 12-month authorizations when criteria are met.
UHC's 2026 PA criteria require ONE of the following lab thresholds:
- Two separate morning total testosterone draws both below 300 ng/dL, OR
- One free testosterone measurement below 50 pg/mL (for patients with borderline total T or elevated SHBG)
In addition, UHC requires documented evaluation to rule out reversible causes of low testosterone — thyroid disorders, sleep apnea, medication effects, significant weight changes, and other conditions that could explain suppressed androgen levels. This is reflected in our 51-biomarker panel, which routinely includes thyroid function, metabolic markers, sleep disorder screening indicators, and HbA1c.
UHC free testosterone threshold: Unlike most carriers that focus solely on total testosterone, UHC's 2026 policy explicitly allows a low free testosterone (below 50 pg/mL) as a standalone criterion for PA approval. This benefits men with elevated SHBG who may have "normal" total T but clinically low bioavailable testosterone. Revive's lab panel includes both total and free testosterone by default.
UHC Formulary: What's Covered and What Isn't
On UHC's formulary, generic testosterone cypionate is placed at Tier 1 — meaning $0–20 per monthly fill for most members after deductible. This makes UHC one of the more favorable carriers for TRT medication cost.
- Tier 1 — Preferred Generic: $0–20 copay. Generic testosterone cypionate. Covered with PA.
- Tier 2 — Non-Preferred Generic: $25–50 copay. Some testosterone formulations may fall here depending on plan.
- Tier 3 — Preferred Brand: $60–120 copay. Brand topical products if covered.
Explicitly NOT covered under UHC's 2026 policy:
- Compounded testosterone: Classified by UHC as "experimental and investigational" and generally not covered.
- Brand Azmiro (testosterone undecanoate nasal gel): Specifically excluded from UHC's 2026 formulary.
Because UHC excludes compounded testosterone, members who fill a compounded prescription usually pay out of pocket, even though their coverage would work with an FDA-approved prescription. Some clinics, including many telehealth companies, send every prescription to their own fulfillment pharmacy and make it hard to use the pharmacy you choose. At Revive, you choose the pharmacy, and we help you pick. See how to choose.
12-Month PA Approval and Annual Reauthorization
When UHC approves TRT coverage, the authorization is valid for 12 months. This means our team submits a PA request once per year rather than every 90 days, significantly reducing administrative burden. Reauthorization requires updated lab work showing that treatment is ongoing and appropriate — the same labs we collect at your regular follow-up visits.
Our team tracks PA expiration dates for all UHC patients and initiates reauthorization automatically before the approval lapses. You won't experience any gap in coverage between annual approvals.
UHC Plan Types and TRT Coverage
UHC Choice Plus (PPO)
The most common UHC employer plan in Washington. Full out-of-network access without referrals, extensive pharmacy network. Revive prescriptions can be filled at Walgreens, CVS, Costco, Fred Meyer, and most pharmacies in UHC's OptumRx network.
UHC Navigate (HMO)
HMO plans may require a PCP referral for specialist care, but the pharmacy benefit works the same. Your UHC HMO drug benefit applies to any prescription filled at an in-network pharmacy, regardless of where the prescription originated.
UHC Medicare Advantage (AARP)
UnitedHealthcare offers Medicare Advantage plans in Washington under the AARP brand. These plans include Part D drug coverage with formulary placement for generic testosterone. Medicare Advantage patients should also review our Medicare TRT coverage guide for additional context on Medicare-specific criteria.
UHC Marketplace Plans
ACA-compliant plans through Washington's Health Benefit Exchange. Generic testosterone must be covered under essential health benefits. Deductibles may be higher but copays after deductible are competitive.
Why UHC Members Choose Revive Over Telehealth
The math for UHC members: your UHC benefit applies to the medication at the pharmacy (see the Tier 1 copay above). Revive visits are cash-pay.
The TRT membership is $35/mo, or $175 every 6 months with the 6-month prepay, plus checkups at $329 every 6 months. Labs: use your insurance, or pay our discounted price (about $40). See What a year costs.
We Meet UHC's PA Documentation Requirements
UHC's 2026 policy requires documentation of hormone levels, symptom history, and reversible cause exclusion.
Our 51-biomarker panel, included with your $99 first visit, covers every lab marker UHC's PA criteria require, including total testosterone, free testosterone, LH, FSH, prolactin, thyroid function, metabolic panel, PSA, CBC, and HbA1c.
For follow-up labs, use your insurance (the lab bills your UHC plan, not Revive) or pay our discounted price (about $40). Our clinical documentation is designed to satisfy UHC's criteria on the first submission.
We Handle All PA Paperwork
Prior authorization for UHC is submitted through the UHC provider portal (uhcprovider.com). Our team handles submission, follow-up, and reauthorization at no additional cost. Standard PA turnaround: 3–5 business days. Our UHC approval rate exceeds 92%.
Copay Estimates for UHC TRT Patients
Injectable Testosterone
Testosterone cypionate 200mg/mL. Tier 1 Preferred Generic. PA required, 12-month approval.
Topical Testosterone
Generic gel with PA. Brand products may require step therapy. Higher copay tier.
Common Questions From UHC Members
When did UHC's TRT policy change?
UHC's Medical Benefit Drug Policy for testosterone replacement therapy was updated effective January 1, 2026. Key changes include the explicit addition of free testosterone as an alternative qualifying criterion and clarification on reauthorization requirements. If you had a prior approval under the previous policy, your 2026 reauthorization will be processed under the updated criteria.
What if my UHC plan has a high deductible?
UHC HDHP plans pair with HSA accounts for pre-tax medical savings. Before your deductible, you pay UHC's negotiated rate for generic testosterone — typically $30–50 per fill. After your deductible, Tier 1 copay of $0–20 applies.
Checkup visits and lab tests are FSA/HSA eligible, and so are prescription medications. The membership fee is not.
Can UHC decline testosterone if "levels are normal"?
UHC's policy uses a specific threshold (total T below 300 ng/dL OR free T below 50 pg/mL), not just "normal range" — which can vary by lab. If your values fall below these thresholds with documented symptoms, UHC is obligated to review the PA under their policy criteria. Our clinical team ensures your documentation meets these specific numeric thresholds before submitting.
Getting Started as a UHC Member
- Step 1: Book your first visit ($99) — doctor consultation + 51-biomarker panel (includes total T, free T, LH, FSH, thyroid, HbA1c, and all UHC-required markers).
- Step 2: Bring your UHC card — we verify your formulary tier, deductible, and PA requirements.
- Step 3: We submit PA under UHC's 2026 Medical Benefit Drug Policy. Standard approval: 3–5 business days.
- Step 4: Pick up your testosterone at Tier 1 — typically $0–20/month for a 12-month authorization.
For full insurance coverage details, visit our insurance coverage page. To understand how our 51-biomarker panel covers every UHC documentation requirement, see our lab testing page.
Related Insurance Guides
UHC Member? We've Got You Covered.
Start with a free phone consult to verify your UHC coverage. We'll handle prior authorization and get your medication covered under the 2026 policy — and your first visit includes a doctor consultation and our 51-biomarker panel.
Prefer to talk it through?
Book your free consult online anytime.